Drug profile · INN
bedaquiline
SIRTURO
bedaquiline (SIRTURO) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antiinfectives for systemic use (J04) J04AK05
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — bedaquiline
- Class
- Antiinfectives for systemic use (J04)
- Route
- —
- Patents
- 0
- Programs
- 6
- Data quality
- 0.83
Quick answer
bedaquiline (SIRTURO) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN bedaquiline
Brand SIRTURO
Therapeutic class Antiinfectives for systemic use (J04)
ATC code J04AK05
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is bedaquiline?
bedaquiline (SIRTURO) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for bedaquiline?
SIRTURO is a marketed brand name for bedaquiline. Check FDA Drugs@FDA for the current US label holder and prescribing information.